MATANO, ELIDE
 Distribuzione geografica
Continente #
NA - Nord America 705
EU - Europa 643
AS - Asia 234
AF - Africa 18
SA - Sud America 2
Totale 1.602
Nazione #
US - Stati Uniti d'America 695
IT - Italia 385
SG - Singapore 116
CN - Cina 91
NL - Olanda 83
UA - Ucraina 50
SE - Svezia 31
DE - Germania 27
FI - Finlandia 21
CI - Costa d'Avorio 18
FR - Francia 15
IE - Irlanda 11
CA - Canada 10
GB - Regno Unito 10
IN - India 10
VN - Vietnam 10
HK - Hong Kong 4
IR - Iran 3
PT - Portogallo 3
AR - Argentina 2
BE - Belgio 2
CZ - Repubblica Ceca 2
GR - Grecia 1
RO - Romania 1
SI - Slovenia 1
Totale 1.602
Città #
Chandler 121
Singapore 103
Amsterdam 82
Ashburn 50
Napoli 44
Millbury 41
Naples 40
Santa Clara 32
Princeton 25
Beijing 22
Jacksonville 22
Milan 22
Nanjing 20
San Giovanni Rotondo 19
Wilmington 12
Boston 11
Des Moines 9
Dong Ket 8
Lawrence 8
Rome 8
Arezzo 7
Munich 7
Ottawa 7
Ann Arbor 6
Rozzano 6
Shenyang 6
Villaricca 6
Boardman 5
Falls Church 5
Jiaxing 5
Nanchang 5
Pune 5
Tianjin 5
Menfi 4
Salerno 4
Washington 4
Woodbridge 4
Caserta 3
Changsha 3
Dallas 3
Dublin 3
Florence 3
Hebei 3
Hong Kong 3
Leawood 3
Menlo Park 3
Redwood City 3
Serravalle Scrivia 3
Soverato Marina 3
Taizhou 3
Toronto 3
Alges 2
Ardabil 2
Ballykisteen 2
Bergamo 2
Castellammare Di Stabia 2
Cipolletti 2
Courcelles 2
Fairfield 2
Frankfurt am Main 2
Frattamaggiore 2
Genova 2
Grumo Nevano 2
Hanoi 2
Houston 2
Kunming 2
Latina 2
Los Angeles 2
Mariano Comense 2
Mugnano Di Napoli 2
Nola 2
Ottaviano 2
Piove Di Sacco 2
Pregnana Milanese 2
Rapolla 2
Rimini 2
Scafati 2
Seattle 2
Suri 2
Torre Annunziata 2
Venezia 2
Andover 1
Arzano 1
Aversa 1
Bangalore 1
Bari 1
Battipaglia 1
Benevento 1
Bozen 1
Caivano 1
Cambridge 1
Cangzhou 1
Capena 1
Castelvetrano 1
Catania 1
Cava De' Tirreni 1
Cesano 1
Cesenatico 1
Darmstadt 1
Duncan 1
Totale 911
Nome #
null 223
Manuale di Oncologia Clinica 101
null 67
Mitoxantrone, etoposide and bleomycin (MEB) chemotherapy in non-Hodgkin's lymphoma patients non-elegible for standard cyclophoshamide, doxorubicin, vincristine and prednisone (CHOP) combination. 55
A case report of limbic encephalitis in a metastatic colon cancer patient during first-line bevacizumab-combined chemotherapy 54
Paraneoplastic sensitive neuropathy associated with anti-hu antibodies in a neuroendocrine tumor of duodenum: a case report. 51
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 51
Chlorambucil, Vincristine and Cytarabine (COA) treatment of low grade lymphomas 49
Systemic treatment of malignant gastrointestinal neuroectodermal tumour after childhood neuroblastoma: chemotherapy in malignant gastrointestinal neuroectodermal tumour 46
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 46
A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients 41
alpha-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies 41
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 40
A-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies. 40
Efficacy of rituximab in gastric diffuse large B cell Lymphoma patients. 38
Basaloid Squamous Cell Carcinoma: A Rare Tumor at the Esophagogastric Junction and an Unexpected Durable Complete Response to FOLFOX-4. 37
Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects. 36
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review 35
High-dose recombinant interleukin-2/verapamil combination in advanced cancer. 34
Heterogeneity of glycolytic phenotype determined by 18F-FDG PET/CT using coefficient of variation in patients with advanced non-small cell lung cancer 33
New Therapeutic Strategies in the Treatment of Stomal Recurrence After Total Laryngectomy: Role of Immunotherapy 33
Core curriculum. Oncologia clinica 33
Impact of COVID-19 pandemic on 2-[18F]FDG PET/CT imaging work-flow in a single medical institution: comparison among the three Italian waves 33
Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. 32
Imatinib mesylate in thymic epithelial malignancies. 32
Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer 32
Brain metastases unresponsive to immunotherapy detected by 18F-FDG-PET/CT in a patient with melanoma 32
Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy 32
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 31
Germ cell tumors in male patients without gonadal involvement: computed tomography/magnetic resonance imaging findings and diagnostic workflow 31
: Low dose dopamine induces early recovery of recombinant Interleukin-2 impaired renal function. 30
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. 29
Phase I clinical trial of high dose recombinant interleukin-2/veparimil combination in advancer cancer. 28
Mitoxantrone, etoposide and bleomycin (MEB) chemotherapy in non-Hodgkin's Lymphoma patients non-elegible for standard cyclophosphamide, doxorubicin vincristine and prednisone (CHOP) combination. 26
CA 15-3 in human breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA). 25
Core curriculum. Oncologia clinica 25
Cardiovascular monitoring of drug-resistant lymphoma patients treated with EPOCH chemotherapy plus high dose verapamil in continuous infusion. 24
Tailored therapy for aggressive non-Hodgkin’s lymphoma: results of a phase II study with a long-term follow-up. 21
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy 19
Coefficient of variation in metastatic lymph nodes determined by 18F-FDG PET/CT in patients with advanced NSCLC: combination with coefficient of variation in primary tumors 8
Totale 1.674
Categoria #
all - tutte 7.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202096 0 0 0 0 9 6 5 6 6 17 22 25
2020/2021169 6 8 25 12 13 25 15 6 27 5 17 10
2021/2022253 9 1 3 1 4 7 9 7 11 35 65 101
2022/2023359 34 22 14 25 41 30 0 26 68 77 16 6
2023/2024266 12 41 27 21 31 40 7 27 6 8 30 16
2024/2025195 61 60 10 11 53 0 0 0 0 0 0 0
Totale 1.674